Significantly, the phase 2 response in neuroblastoma cells due to CDDO-MA was translated functionally by a dose dependent increase in cellular GSH production, one of the major cellular antioxidants under the regulatory control of Nrf2/ARE signaling [20]. Here, NFE2L2 is linked to neuroblastoma.